纵横研报
Ticker Detail

600252.SHG

¥2.19+0.00% 中恒集团 Drug Manufacturers - Specialty & Generic
00Reports China 医疗健康
Guangxi Wuzhou Zhongheng Group Co Ltd
医疗健康 · 专科与仿制药

Guangxi Wuzhou Zhongheng Group Co., Ltd, together with its subsidiaries, researches, develops, manufactures, and sells pharmaceuticals in China. The company offers traditional Chinese medicine, including Xueshuantong injection, Zhonghua Dieda Wan for traumatic injuries, Fuyanjing capsules, JieShiTong tablets, snake gall and fritillaria liquid, Kunyuean granules, and compound clam oral liquid for cardiovascular and cerebrovascular, neurology, endocrinology, orthopedics, ophthalmology, gynecology, pediatrics, respiratory, urinary system, and other healthcare applications. It also provides clindamycin hydrochloride injection, esomeprazole sodium injection, esomeprazole magnesium enteric-coated capsules, cefoperazone dry suspension, naloxone hydrochloride injection, and fludarabine phosphate injection. Further, the company is involved in production of oral care, clothing care, and home care products, including toothpaste; health food business; pharmaceutical distribution; project investment and management; real estate development and operation; and cosmetic products businesses. Guangxi Wuzhou Zhongheng Group Co., Ltd was founded in 1993 and is based in Wuzhou, China.

MARKET 市值 6.27B CNY 52W ¥1.71 – ¥3.23 EODHD · Q 2026-03-31 · 同步 2026-07-12
QUALITY PEG 营收 YoY -31.9% ROE -7.7% 营业利润率 -4.0% 净利润率 -25.8%

暂无相关研报

数据库中已收录该标的的基本面数据,可发起一份定制研报。

CUSTOM RESEARCH · 定制研报 没找到完全契合的标的?让我们替你做一份。 告诉我们你关心的标的与偏好,1 个工作日内在站内上线。 开始定制